Last update 20 Mar 2026

JX2105

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
JX2105
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic Disease
Active Indication
Parkinson Disease
Inactive Indication-
Originator Organization
Zhejiang Jingxin Pharmaceutical Co., Ltd.Zhejiang Jingxin Pharmaceutical Co., Ltd.
Active Organization
Zhejiang Jingxin Pharmaceutical Co., Ltd.Zhejiang Jingxin Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with JX2105
NCT06537050
/ Enrolling by invitationPhase 1
A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese Subjects The Purpose of the Study is to Evaluate the Safety, Tolerability After Administration of Single Dose or Multiple Doses, and the Pharmacokinetics (PK) of Single and Multiple Doses of JX2105 in Healthy Study Participants.
100 Clinical Results associated with JX2105
Login to view more data
100 Translational Medicine associated with JX2105
Login to view more data
100 Patents (Medical) associated with JX2105
Login to view more data
100 Deals associated with JX2105
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Parkinson DiseasePhase 1
China
Zhejiang Jingxin Pharmaceutical Co., Ltd.Zhejiang Jingxin Pharmaceutical Co., Ltd.
01 Jul 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free